Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
76,566,375
-
Total 13F shares
-
38,771,794
-
Share change
-
+37,746,564
-
Total reported value
-
$1,702,050,458
-
Price per share
-
$43.90
-
Number of holders
-
96
-
Value change
-
+$1,657,042,866
-
Number of buys
-
92
Institutional Holders of CG Oncology, Inc. - Common Stock (CGON) as of Q1 2024
As of 31 Mar 2024,
CG Oncology, Inc. - Common Stock (CGON) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,771,794 shares.
The largest 10 holders included
Decheng Capital LLC, TCG Crossover Management, LLC, BlackRock Inc., VANGUARD GROUP INC, BVF INC/IL, JANUS HENDERSON GROUP PLC, Avidity Partners Management LP, RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, and BRAIDWELL LP.
This page lists
96
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.